APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,134,357 | -77.9% | 450,430 | -47.1% | 0.00% | -80.0% |
| Q2 2023 | $77,641,980 | +35.4% | 852,272 | -1.9% | 0.02% | +36.4% |
| Q1 2023 | $57,331,641 | +29.4% | 869,188 | +1.4% | 0.01% | +22.2% |
| Q4 2022 | $44,321,727 | -23.6% | 857,121 | +0.9% | 0.01% | -30.8% |
| Q3 2022 | $58,000,000 | +54.0% | 849,188 | +2.0% | 0.01% | +62.5% |
| Q2 2022 | $37,654,000 | -3.2% | 832,698 | +8.8% | 0.01% | +14.3% |
| Q1 2022 | $38,880,000 | +10.5% | 765,202 | +2.9% | 0.01% | +16.7% |
| Q4 2021 | $35,171,000 | +61.0% | 743,867 | +12.3% | 0.01% | +50.0% |
| Q3 2021 | $21,842,000 | -48.8% | 662,686 | -1.8% | 0.00% | -50.0% |
| Q2 2021 | $42,628,000 | +49.5% | 674,497 | +1.5% | 0.01% | +60.0% |
| Q1 2021 | $28,506,000 | -27.6% | 664,324 | -3.5% | 0.01% | -37.5% |
| Q4 2020 | $39,364,000 | +84.8% | 688,184 | -2.5% | 0.01% | +60.0% |
| Q3 2020 | $21,306,000 | -6.5% | 706,160 | +1.2% | 0.01% | 0.0% |
| Q2 2020 | $22,792,000 | +24.2% | 697,884 | +1.9% | 0.01% | 0.0% |
| Q1 2020 | $18,348,000 | +3.5% | 684,869 | +18.3% | 0.01% | +25.0% |
| Q4 2019 | $17,729,000 | +24.4% | 579,002 | -2.1% | 0.00% | +33.3% |
| Q3 2019 | $14,246,000 | +20.0% | 591,400 | +26.2% | 0.00% | 0.0% |
| Q2 2019 | $11,872,000 | +38.3% | 468,532 | +6.5% | 0.00% | +50.0% |
| Q1 2019 | $8,582,000 | +49.3% | 440,032 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $5,747,000 | -26.8% | 435,728 | -1.3% | 0.00% | 0.0% |
| Q3 2018 | $7,852,000 | -16.4% | 441,666 | +3.4% | 0.00% | 0.0% |
| Q2 2018 | $9,395,000 | +255.9% | 427,029 | +257.5% | 0.00% | +100.0% |
| Q1 2018 | $2,640,000 | +5.7% | 119,443 | +3.7% | 0.00% | 0.0% |
| Q4 2017 | $2,498,000 | – | 115,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |